#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heart disease congenital Anaplastic thyroid cancer Angelman's syndrome Hereditary hypophosphataemic rickets Cutaneous T-cell lymphoma stage II Hereditary spastic paraplegia Mycobacterium abscessus infection Follicular lymphoma stage III Hyperchylomicronaemia Chorioretinitis Neurodevelopmental disorder Piriformis syndrome Chronic myelomonocytic leukaemia Congenital leptin deficiency Salivary gland cancer More trials…

    Learn about Rare Diseases

    Acquired haemophilia Glomerulonephritis membranoproliferative – Basic Information Synovial sarcoma metastatic – Treatment Paraneoplastic neurological syndrome Inclusion body myositis – Treatment Marginal zone lymphoma refractory Congenital hypotransferrinaemia Pleomorphic leiomyosarcoma – Life with Disease Langerhans’ cell histiocytosis – Trials in Disease Brain stem glioma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Procarbazine Hydrochloride Etrumadenant Dolutegravir Sodium Anhydrous Cidofovir Dactylis Glomerata Epirubicin Hydrochloride Belzupacap Sarotalocan Brexucabtagene Autoleucel GSKVX000000030918 Varnimcabtagene Autoleucel R-Azasetron Besilate Lurasidone INSULIN DEGLUDEC Timbetasin Acetate Levodropropizine Triheptanoin Fenebrutinib Rifapentine POLYSORBATE 80 Thiocolchicoside More therapies…

    Learn about Your Condition

    Cervix carcinoma stage IV Alcohol use disorder Factor IX deficiency Metastasis Cardiac failure chronic Synovial sarcoma Oedema peripheral Aplasia pure red cell Oesophageal carcinoma Appendicitis perforated Nephropathy Pancreatic carcinoma stage IV Congenital ureteric anomaly Cardiac failure Rubella More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study of BP05 and Ranibizumab Efficacy and Safety in Patients with Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Latvia Slovakia

  • Study on the Safety and Effectiveness of Ripasudil Eye Drops for Patients with Fuchs Endothelial Corneal Dystrophy After Descemetorhexis

    Not recruiting

    3 1
    Investigated Diseases:
    • Corneal dystrophy
    Investigated Drugs:
    • Ripasudil
    Denmark Germany Spain

  • Study on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Uveitis
    Investigated Drugs:
    • Fluorescein Sodium
    • Baricitinib
    • Prednisone
    France

  • Study Comparing Aflibercept and Placebo for Patients with Macular Telangiectasia Type 1

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Macular telangiectasia
    Investigated Drugs:
    • Aflibercept
    France

  • Study of Danicopan for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration

    Not recruiting

    2 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Danicopan
    Czechia France Germany Hungary Italy Latvia +2

  • Long-Term Safety and Efficacy Study of Botaretigene Sparoparvovec for Patients with X-Linked Retinitis Pigmentosa

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Botaretigene Sparoparvovec
    • Cefazolin Sodium
    Belgium Denmark France Italy The Netherlands Spain
Previous Page
1 … 28 29 30 31 32 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!